The production of pharmaceutical grade magnesium oxide need two-way examination

With strongly advocate of environmental policy, the raw medicine enterprise like pharmaceutical grade magnesium oxide manufacturers are faced with production contradiction. Raw medicine production has become key focus areas of relevant departments to promote energy saving and environmental protection, in particular in the production of energy consumption greatly. After the development and reform commission (NDRC) adjusting the no-pollution emission standards from single examination to two-way examination combined single examination with total amount control, they put forward higher request to the domestic raw medicine production enterprises.

Hebei Meishen Chemical Technology Group has a large number of branches, Xingtai Metallurgy Magnesium Industry Co.,Ltd is one of the subsidiary company specializing in the production of pharmaceutical grade magnesium salt series products. Its predecessor is a state-owned enterprise, and it has been the national pharmaceutical grade magnesium salt products designated units for dozens of years. Hebei Meishen Chemical Technology Group conducted a series of equipment reform and technological innovation, making production capacity more powerful. No matter in the energy conservation or environmental protection, we had already walked in the forefront of the international, and  populated by  the majority of customers.

Judging from the current situation, domestic pharmaceutical production enterprises should strike a balance among economic benefits and environmental pollution, grasp the market opportunity in the process of research and development production, continuously improve equipment energy conservation and environmental protection performance, in order to improve the efficiency of magnesium oxide production and resources.